Table 10.
Comparison in terms of average number of features selected with existing studies in 100 feature selection runs.
| Dataset | Method | Proposed BEV | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PSO | ECLPSO | CSO | FSBACOM | TFSACO | IRRFSACO | TSHFS-ACO | VLPSO | ERM-FS | ||
| Lung cancer | 6234.7 | 5739.7 | 226.4 | 379.1 | 61.9 | 96.0 | 96.3 | 181.0 | 61.00 | 12.1 |
| 11 tumor | 6205.0 | 5731.7 | 588.6 | 339.6 | 93.7 | 146.0 | 145.9 | 204.4 | 292.60 | 430.6 |
| Leukemia 2 | 5535.7 | 5115.6 | 88.6 | 363.0 | 32.2 | 56.0 | 55.9 | 42.7 | 15.30 | 5.6 |
| Prostate | 5193.7 | 4818.5 | 357.2 | 420.9 | 12.2 | 65.0 | 64.89 | 38.08 | 11.00 | 6.4 |
| Brain tumor 2 | 5117.2 | 4718.7 | 90.43 | 218.5 | 46.8 | 74.0 | 74.1 | 113.6 | 26.80 | 6.5 |
| Brain tumor 1 | 2917.2 | 2710.0 | 207.6 | 120.5 | 38.7 | 71.0 | 70.9 | 103.8 | 32.44 | 7.3 |
| 9 tumor | 2811.9 | 2605.5 | 220.3 | 123.9 | 79.9 | 89.0 | 89.2 | 87.6 | 89.40 | 108 |
| DLBCL | 2681.0 | 2491.3 | 30.1 | 173.9 | 17.4 | 45.0 | 45.0 | 31.9 | 14.20 | 6.0 |
| Leukemia 1 | 2615.5 | 2427.9 | 170.1 | 130.1 | 37.8 | 45.0 | 44.5 | 7.0 | 22.80 | 6.1 |
| SRBCT | 1119.4 | 1054.8 | 85.4 | 35.8 | 49.8 | 43.0 | 42.5 | 23.4 | 31.00 | 10.4 |
Significant values are in bold.